# Kyverna Therapeutics Inc. COM

Kyverna Therapeutics Inc. COM is a security (CUSIP 501976104) tracked across SEC portfolio filings. 118 institutional managers reported $317.9M on Form 13F as of 2026-06-30; 7 registered fund positions totaling $14.4M via N-PORT as of 2026-03-31.

## Summary

- Issuer: Kyverna Therapeutics Inc.
- Class: COM
- CUSIP: 501976104
- Asset category: EC
- 13F holders: 118
- 13F value: $317.9M
- 13F period: 2026-06-30
- N-PORT fund positions: 7
- N-PORT value: $14.4M
- N-PORT report: 2026-03-31

## Top institutional holders (Form 13F)

_Showing 15 of 118 managers by value._

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| GILEAD SCIENCES, INC. | FOSTER CITY, CA | $36.8M | 4,126,119 |
| GordonMD Global Investments LP | Beverely Hills, CA | $36.6M | 4,244,818 |
| [Vida Ventures Advisors, LLC](https://search.stillhousedata.com/firm/304396) | Boston, MA | $27.1M | 4,523,924 |
| Bain Capital Life Sciences Investors, LLC | Boston, MA | $26.8M | 3,110,000 |
| AIGH Capital Management LLC | BALTIMORE, MD | $17.3M | 2,000,000 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | New York, NY | $17.3M | 2,000,000 |
| [VANGUARD GROUP INC](https://search.stillhousedata.com/firm/105958) | Valley Forge, PA | $16.7M | 1,781,257 |
| [Balyasny Asset Management L.P.](https://search.stillhousedata.com/firm/138111) | Chicago, IL | $9.7M | 1,125,321 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $8.7M | 1,005,508 |
| Insight Holdings Group, LLC | NEW YORK, NY | $8.5M | 989,054 |
| MORGAN STANLEY | NEW YORK, NY | $8.4M | 977,289 |
| BlackRock, Inc. | New York, NY | $7.6M | 877,078 |
| [Woodline Partners LP](https://search.stillhousedata.com/firm/301480) | San Francisco, CA | $7.3M | 845,325 |
| D. E. Shaw & Co., Inc. | New York, NY | $6.2M | 721,581 |
| [Propel Bio Management, LLC](https://search.stillhousedata.com/firm/322858) | LOS ANGELES, CA | $5.6M | 644,421 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [T. Rowe Price Health Sciences Fund, Inc.](https://search.stillhousedata.com/fund/S000002088) | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $9.9M | 9.05% |
| [VANGUARD EXTENDED MARKET INDEX FUND](https://search.stillhousedata.com/fund/S000002841) | VANGUARD INDEX FUNDS | $3.4M | 0.42% |
| [T. Rowe Price Health Sciences Portfolio](https://search.stillhousedata.com/fund/S000002083) | T. ROWE PRICE EQUITY SERIES, INC. | $696K | 10.51% |
| [VANGUARD BALANCED INDEX FUND](https://search.stillhousedata.com/fund/S000002560) | VANGUARD VALLEY FORGE FUNDS | $194K | 0.03% |
| [VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND](https://search.stillhousedata.com/fund/S000002855) | VANGUARD INSTITUTIONAL INDEX FUNDS | $146K | 0.05% |
| [Federated Hermes Managed Volatility Fund II](https://search.stillhousedata.com/fund/S000009746) | Federated Hermes Insurance Series | $104K | 6.07% |
| [Blackstone Alternative Multi-Strategy Fund](https://search.stillhousedata.com/fund/S000045538) | Blackstone Alternative Investment Funds | $7K | 0.02% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/501976104.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.